Home > Healthcare > Pharmaceuticals > Active Pharmaceutical Ingredients > Ibuprofen API Market
Ibuprofen API Market was valued at USD 694.4 million in 2023 and is anticipated to grow at a CAGR of 3.7% between 2024 – 2032. The increasing prevalence of inflammatory diseases such as arthritis and rheumatoid arthritis has led to a rising demand for ibuprofen API, as it is widely used to alleviate pain and reduce inflammation.
Additionally, the growing geriatric population globally, which is more prone to such conditions, further fuels the demand for ibuprofen API. Moreover, the rising trend of self-medication, supported by the easy availability of over-the-counter ibuprofen products, is also a significant driver of market growth. Furthermore, the expanding pharmaceutical industry and the continual introduction of innovative formulations and combination products containing ibuprofen API are expected to contribute to market expansion in the coming years.
Ibuprofen API refers to the active pharmaceutical ingredient of the medication ibuprofen. Active pharmaceutical ingredients are the biologically active component responsible for the therapeutic effects of the drug. Ibuprofen API is widely used in various formulations such as tablets, capsules, and suspensions, and it is available both over the counter and by prescription.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Ibuprofen API Market Size in 2023: | USD 694.4 Million |
Forecast Period: | 2024 – 2032 |
Forecast Period 2024 – 2032 CAGR: | 3.7% |
2024 – 2032 Value Projection: | USD 953.4 Million |
Historical Data for: | 2021 – 2023 |
No. of Pages: | 112 |
Tables, Charts & Figures: | 200 |
Segments covered: | Type, Application, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|